Pieris Pharmaceuticals earns third milestone payment from Sanofi
Biotechnology company Pieris Pharmaceuticals announced Monday that it received a milestone payment of an undisclosed amount from Sanofi for the continuous advancement of the tetraspecific Anticalin-based program for infectious disease. Read More »